Lpl Financial LLC Fate Therapeutics Inc Transaction History

Lpl Financial LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$47.84 - $64.34 $164,760 - $221,586	-3,444 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.27 - $95.73 $36,095 - $58,299	609 Added 21.48%	3,444 $204,000
Q2 2021 Aug 13, 2021	BUY	$67.25 - $92.52 $190,653 - $262,294	2,835 New	2,835 $246,000

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $222M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.